BioTelemetry, Inc. to Release Second Quarter 2020 Earnings Results on July 30, 2020
BioTelemetry, Inc. (NASDAQ: BEAT) will announce its second quarter 2020 earnings on July 30 at 4:00 PM ET, followed by a conference call at 5:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioTelemetry, Inc. (NASDAQ: BEAT) will announce its second quarter 2020 earnings on July 30 at 4:00 PM ET, followed by a conference call at 5:00 PM ET. The call will be accessible via the investor section of the BioTelemetry website. The company, a leader in remote medical technology, offers services including remote cardiac monitoring and centralized laboratory services for clinical trials. This announcement may set expectations for the company’s financial performance ahead of the earnings release.
Details
News Market Reaction – BEAT
The recorded move for BEAT in the trading session of this news was -2.94%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, July 30, 2020. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on the website for two weeks.
About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing that serves both healthcare and clinical research customers. More information can be found at www.gobio.com.
Contact:
BioTelemetry, Inc.
Heather C. Getz
Investor Relations
Executive Vice President, Chief Financial Officer
800-908-7103
InvestorRelations@biotelinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.